Literature DB >> 2838897

Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus.

R Omdal1, S I Mellgren, G Husby.   

Abstract

Thirty patients with SLE were studied retrospectively and subjected to clinical neurological examination. The accumulated neurological manifestations from the beginning of the disease until the time of examination were thus collected. Twenty-five patients (83%) had experienced neuropsychiatric manifestations while 11 patients (37%) had neuromuscular manifestations. The most frequent single symptom was migraine which had occurred in 40% of the patients. This was followed by severe protracted headache in 20%, vertigo in 20%, and psychiatric problems in 17%. Carpal tunnel syndrome and muscular weakness both occurring in 23% of the patients were the most prevalent neuromuscular manifestations, followed by myositis in 10%.

Entities:  

Mesh:

Year:  1988        PMID: 2838897     DOI: 10.3109/03009748809098770

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  7 in total

Review 1.  Peripheral nervous system lesion syndromes and the mechanisms of their formation in connective tissue diseases.

Authors:  N N Spirin; V A Bulanova; N V Pizova; N P Shilkina
Journal:  Neurosci Behav Physiol       Date:  2007-01

2.  Hippocampal atrophy in systemic lupus erythematosus.

Authors:  S Appenzeller; A D Carnevalle; L M Li; L T L Costallat; F Cendes
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

Review 3.  Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).

Authors:  R A Asherson; S D Denburg; J A Denburg; R M Carbotte; N Futrell
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

4.  Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids.

Authors:  H S Markus; N Hopkinson
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

5.  Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate.

Authors:  G Valesini; R Priori; A Francia; G Balestrieri; A Tincani; P Airo; R Cattaneo; A Zambruni; B Troianello; M Chofflon
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Posterior reversible encephalopathy syndrome could be an underestimated variant of "reversible neurological deficits" in Systemic Lupus Erythematosus.

Authors:  Bin Liu; Xuan Zhang; Feng-Chun Zhang; Yuan Yao; Ri-Zhi Zhou; Miao-Miao Xin; Li-Qin Wang
Journal:  BMC Neurol       Date:  2012-12-05       Impact factor: 2.474

7.  Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein.

Authors:  V G Hanson; M Horowitz; D Rosenbluth; H Spiera; S Puszkin
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.